Talking Biotech with Dr. Kevin Folta
Science:Life Sciences
Jesus Martin-Garcia: New Therapies for HERV-Based Disease
2022-02-13
Human Endogenous Retroviruses (HERVs) comprise 8% of the human genome and are relics of ancient infections, some dating back to pre-human primates. These resident viral elements can be awakened by viral infections, and have been shown to be tightly associated with diseases like Multiple Sclerosis (MS) and Amyotrophic Lateral Sclerosis (ALS). New data suggest a role for HERVs in the neurological symptoms of long COVID. Today's podcast features a conversation with Jesus Martin-Garcia, CEO and Co-Founder of GeNeuro. New therapies target the rogue proteins arising from these ancient viruses, and show promise in treating, if not reversing, disease progression.
Follow GeNeuro on Twitter
GeNeuro Website http://www.geneuro.com/
YouTube Videos of their technology
# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/
# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq
The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
More Episodes
2018-08-25
2018-08-18
2018-08-11
2018-08-04
2018-07-28
2018-07-21
2018-07-14
2018-07-07
2018-06-30
2018-06-23
2018-06-16
2018-06-09
2018-06-02
2018-05-26
2018-05-19
2018-05-12
2018-05-05
2018-04-14
Get this podcast on your
phone, FREE
